News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,933 Results
Type
Article (40686)
Company Profile (271)
Press Release (676970)
Multimedia
Podcasts (76)
Webinars (17)
Section
Business (204697)
Career Advice (2018)
Deals (35522)
Drug Delivery (105)
Drug Development (81311)
Employer Resources (173)
FDA (16370)
Job Trends (14930)
News (346305)
Policy (32707)
Tag
Academia (2560)
Accelerated approval (22)
Adcomms (24)
Allergies (122)
Alliances (49641)
ALS (157)
Alzheimer's disease (1619)
Antibody-drug conjugate (ADC) (260)
Approvals (16536)
Artificial intelligence (450)
Autoimmune disease (112)
Automation (33)
Bankruptcy (362)
Best Places to Work (11638)
BIOSECURE Act (20)
Biosimilars (170)
Biotechnology (176)
Bladder cancer (142)
Brain cancer (51)
Breast cancer (573)
Cancer (4340)
Cardiovascular disease (355)
Career advice (1700)
Career pathing (34)
CAR-T (260)
CDC (44)
Celiac Disease (1)
Cell therapy (678)
Cervical cancer (34)
Clinical research (68928)
Collaboration (1442)
Company closure (4)
Compensation (1023)
Complete response letters (46)
COVID-19 (2691)
CRISPR (81)
C-suite (674)
Cystic fibrosis (135)
Data (5605)
Decentralized trials (2)
Denatured (25)
Depression (111)
Diabetes (452)
Diagnostics (6598)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (210)
Drug pricing (166)
Drug shortages (28)
Duchenne muscular dystrophy (207)
Earnings (89725)
Editorial (50)
Employer branding (21)
Employer resources (151)
Events (116586)
Executive appointments (936)
FDA (19064)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1309)
Gene editing (179)
Generative AI (38)
Gene therapy (530)
GLP-1 (911)
Government (4625)
Grass and pollen (6)
Guidances (375)
Healthcare (18858)
HIV (47)
Huntington's disease (39)
IgA nephropathy (75)
Immunology and inflammation (227)
Immuno-oncology (34)
Indications (75)
Infectious disease (2930)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (100)
Intellectual property (209)
Interviews (315)
IPO (16621)
IRA (48)
Job creations (3641)
Job search strategy (1427)
Kidney cancer (15)
Labor market (79)
Layoffs (541)
Leadership (28)
Legal (7943)
Liver cancer (87)
Longevity (12)
Lung cancer (605)
Lymphoma (347)
Machine learning (37)
Management (59)
Manufacturing (660)
MASH (151)
Medical device (13681)
Medtech (13717)
Mergers & acquisitions (19854)
Metabolic disorders (1130)
Multiple sclerosis (139)
NASH (16)
Neurodegenerative disease (276)
Neuropsychiatric disorders (69)
Neuroscience (2689)
NextGen: Class of 2025 (6521)
Non-profit (4500)
Now hiring (60)
Obesity (524)
Opinion (248)
Ovarian cancer (149)
Pain (166)
Pancreatic cancer (188)
Parkinson's disease (251)
Partnered (31)
Patents (442)
Patient recruitment (382)
Peanut (53)
People (58542)
Pharmaceutical (64)
Pharmacy benefit managers (26)
Phase I (21478)
Phase II (30344)
Phase III (22618)
Pipeline (3678)
Policy (260)
Postmarket research (2564)
Preclinical (9159)
Press Release (64)
Prostate cancer (211)
Psychedelics (42)
Radiopharmaceuticals (258)
Rare diseases (697)
Real estate (5952)
Recruiting (69)
Regulatory (23876)
Reports (51)
Research institute (2372)
Resumes & cover letters (351)
Rett syndrome (22)
RNA editing (12)
RSV (73)
Schizophrenia (134)
Series A (211)
Series B (165)
Service/supplier (11)
Sickle cell disease (91)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (40)
Startups (3609)
State (2)
Stomach cancer (16)
Supply chain (96)
Tariffs (80)
The Weekly (49)
Vaccines (940)
Venture capital (71)
Weight loss (339)
Women's health (72)
Worklife (17)
Date
Today (5)
Last 7 days (615)
Last 30 days (2185)
Last 365 days (30178)
2025 (29346)
2024 (35222)
2023 (40084)
2022 (51180)
2021 (55718)
2020 (54091)
2019 (46553)
2018 (35020)
2017 (32121)
2016 (31492)
2015 (37569)
2014 (31344)
2013 (26375)
2012 (28599)
2011 (29290)
2010 (27359)
Location
Africa (734)
Alabama (77)
Alaska (7)
Arizona (287)
Arkansas (13)
Asia (38932)
Australia (6362)
California (10313)
Canada (3072)
China (954)
Colorado (431)
Connecticut (443)
Delaware (303)
Europe (83988)
Florida (1529)
Georgia (328)
Hawaii (2)
Idaho (61)
Illinois (775)
India (54)
Indiana (485)
Iowa (20)
Japan (357)
Kansas (122)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1303)
Massachusetts (7439)
Michigan (299)
Minnesota (580)
Mississippi (5)
Missouri (118)
Montana (30)
Nebraska (26)
Nevada (111)
New Hampshire (73)
New Jersey (2789)
New Mexico (28)
New York (2753)
North Carolina (1348)
North Dakota (8)
Northern California (4941)
Ohio (302)
Oklahoma (20)
Oregon (38)
Pennsylvania (2114)
Puerto Rico (19)
Rhode Island (45)
South America (1102)
South Carolina (58)
South Dakota (1)
Southern California (3990)
Tennessee (161)
Texas (1587)
United States (36872)
Utah (306)
Vermont (1)
Virginia (236)
Washington D.C. (78)
Washington State (844)
West Virginia (4)
Wisconsin (89)
Wyoming (2)
717,933 Results for "microbix biosystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Microbix Schedules Release of Results for Q4 Fiscal 2025
December 12, 2025
·
3 min read
Press Releases
Microbix Launches New Products to Support H3N2 Flu Testing
December 10, 2025
·
5 min read
Press Releases
Microbix Assisting EMQN with Second Genetic-Test EQA Program
September 23, 2025
·
6 min read
Press Releases
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
September 18, 2025
·
6 min read
Press Releases
Microbix Reports Results for Q3 Fiscal 2025
August 15, 2025
·
8 min read
Press Releases
Microbix’s Clot-Buster Drug Project Advances
May 5, 2025
·
5 min read
Microbix Advances Test-Ingredient Manufacturing Capabilities
Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces that it has successfully adapted and extended the use of its bioreactor capabilities for production of another clinically and commercially-important test-ingredient.
June 4, 2024
·
5 min read
Press Releases
Microbix Schedules Release of Results for Q3 Fiscal 2025 Results Release and Webinar Discussion on Morning of August 14, 2025
August 7, 2025
·
3 min read
Microbix’s Clot-Buster Drug Project Advances
Microbix Biosystems Inc. announces that its funding and commercialization partner, Sequel Pharma, LLC, has executed, with support from Microbix, an agreement with a leading international contract development and manufacturing organization for production of the active ingredient of Kinlytic® urokinase, a biologic drug for dissolving blood clots.
March 14, 2024
·
5 min read
Business
Microbix Reports Strong Results for Q2 Fiscal 2024
Microbix Biosystems Inc. reports results for its second quarter and first half of fiscal 2024 ended March 31, 2024.
May 15, 2024
·
7 min read
1 of 71,794
Next
